Back
Speaker illustration

Professor David Lanfear

Henry Ford Hospital, Detroit (United States of America)

Member of:

European Society of Cardiology
Heart Failure Association

Professor DAVID E. LANFEAR, MD, MS is Vice President, Clinical and Translational Research and Co-Director of the Center for Individualized and Genomic Medicine Research at Henry Ford Health. Dr. Lanfear is a Heart Failure Physician and Scientist with a track record of clinical trial leadership and NIH funded projects focused on precision medicine and genomics in heart failure. He has more than 150 published manuscripts reaching high-impact journals including NEJM, JAMA, JACC, and Circulation: Heart Failure. Dr. Lanfear is an Associate Editor at Circulation: Heart Failure and a national leader in academic societies serving currently on ACC Accreditation Oversight Committee, AHA GPM Nominating committee, HFSA Program Committee, and having previously served on the ACC Heart Failure/Tx leadership committee, AHA Genomics and Precision Medicine Leadership committee, and HFSA Board of Directors.

Presentations Articles

Mitochondrial function is abnormal in circulating blood monocytes of patients with chronic heart failure

Event: ESC Congress 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Further insights into inflammation, immunology, and insulin resistance in heart failure

Access
Thumbnail

Plasma proteomic profile predicts survival in heart failure with reduced ejection fraction

Event: ESC Congress 2019

Topic: Biomarkers

Session: Obesity in Heart Failure

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb